FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897585685> ?p ?o ?g. }

• W2897585685 endingPage "1129" @default.
• W2897585685 startingPage "1120" @default.
• W2897585685 abstract "Objective Identify population pharmacokinetics and pharmacodynamic target attainment of gentamicin in neonates with hypoxic‐ischemic encephalopathy ( HIE ) undergoing controlled hypothermia ( CH ). Design Prospective open‐label pharmacokinetic study. Gentamicin concentrations were modeled and dosing regimens simulated for a 5000‐patient neonatal population with HIE receiving CH using PM etrics, a nonparametric, pharmacometric modeling, and simulation package for R. Setting A 189‐bed children's tertiary care teaching hospital. Results Twelve patients, 5 (42%) females and 7 (58%) males, met inclusion criteria with a median gestation age of 39.9 weeks (interquartile range [IQR] 38.5–40.2 wks) and a median birthweight ( BW ) of 3.3 kg (IQR 3.1–3.7 kg). Gentamicin concentrations were best described by a two‐compartment model with first‐order elimination with BW as a covariate on volume of distribution (Vd). The mean total body population clearance ( CL ) was 2.2 ± 0.7 ml/minute/kg, and the volume of the central compartment was 0.44 ± 0.06 L/kg. The R 2 , bias, and precision for the observed versus population predicted model were 0.917, 1.15, and 10.9 μg/ml; the R 2 , bias, and precision for the observed versus individual predicted model were 0.982, −0.132, and 0.932 μg/ml, respectively. The calculated mean population estimate for the total Vd was 0.96 ± 0.4 L/kg. The dosing regimen that most consistently produced a maximum concentration (C max ) in the range of 10–12 mg/L with a minimum concentration (C min ) level less than 2 mg/L was 5 mg/kg/dose given every 36 hours. Conclusion These data suggest the population pharmacokinetics of gentamicin in neonates with HIE receiving CH have an increase in gentamicin CL and are different from previous reports in neonates with HIE not receiving CH and/or neonates without HIE . This analysis suggests a dosing regimen of 5 mg/kg/dose every 36 hours results in a gentamicin C max within the range of 10–12 mg/L with a C min lower than 2 mg/L, which is appropriate for treating susceptible gram‐negative organisms with minimum inhibitory concentrations of 1 mg/L or lower." @default.
• W2897585685 created "2018-10-26" @default.
• W2897585685 creator A5003640432 @default.
• W2897585685 creator A5025910111 @default.
• W2897585685 creator A5034050749 @default.
• W2897585685 creator A5068291584 @default.
• W2897585685 creator A5074421228 @default.
• W2897585685 date "2018-10-24" @default.
• W2897585685 modified "2023-10-14" @default.
• W2897585685 title "Population Pharmacokinetics of Gentamicin in Neonates with Hypoxemic-Ischemic Encephalopathy Receiving Controlled Hypothermia" @default.
• W2897585685 cites W1501112436 @default.
• W2897585685 cites W1966387915 @default.
• W2897585685 cites W1967370579 @default.
• W2897585685 cites W1976377445 @default.
• W2897585685 cites W1977719679 @default.
• W2897585685 cites W1997364324 @default.
• W2897585685 cites W2002593789 @default.
• W2897585685 cites W2006333306 @default.
• W2897585685 cites W2006979467 @default.
• W2897585685 cites W2017632705 @default.
• W2897585685 cites W2018518196 @default.
• W2897585685 cites W2021298363 @default.
• W2897585685 cites W2032121224 @default.
• W2897585685 cites W2032203568 @default.
• W2897585685 cites W2054417772 @default.
• W2897585685 cites W2062236764 @default.
• W2897585685 cites W2066215889 @default.
• W2897585685 cites W2066543180 @default.
• W2897585685 cites W2089589050 @default.
• W2897585685 cites W2091277908 @default.
• W2897585685 cites W2096941946 @default.
• W2897585685 cites W2132491970 @default.
• W2897585685 cites W2143342896 @default.
• W2897585685 cites W2152073293 @default.
• W2897585685 cites W2156206801 @default.
• W2897585685 cites W2164127547 @default.
• W2897585685 cites W2171142028 @default.
• W2897585685 cites W2234052494 @default.
• W2897585685 cites W2301075763 @default.
• W2897585685 cites W2325172100 @default.
• W2897585685 cites W2337766048 @default.
• W2897585685 cites W2590534393 @default.
• W2897585685 cites W2810571275 @default.
• W2897585685 cites W2830314014 @default.
• W2897585685 cites W2907198977 @default.
• W2897585685 doi "https://doi.org/10.1002/phar.2186" @default.
• W2897585685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30300445" @default.
• W2897585685 hasPublicationYear "2018" @default.
• W2897585685 type Work @default.
• W2897585685 sameAs 2897585685 @default.
• W2897585685 citedByCount "4" @default.
• W2897585685 countsByYear W28975856852019 @default.
• W2897585685 countsByYear W28975856852020 @default.
• W2897585685 countsByYear W28975856852021 @default.
• W2897585685 crossrefType "journal-article" @default.
• W2897585685 hasAuthorship W2897585685A5003640432 @default.
• W2897585685 hasAuthorship W2897585685A5025910111 @default.
• W2897585685 hasAuthorship W2897585685A5034050749 @default.
• W2897585685 hasAuthorship W2897585685A5068291584 @default.
• W2897585685 hasAuthorship W2897585685A5074421228 @default.
• W2897585685 hasConcept C112705442 @default.
• W2897585685 hasConcept C119060515 @default.
• W2897585685 hasConcept C126322002 @default.
• W2897585685 hasConcept C139254425 @default.
• W2897585685 hasConcept C141071460 @default.
• W2897585685 hasConcept C177713679 @default.
• W2897585685 hasConcept C2777288759 @default.
• W2897585685 hasConcept C2777390192 @default.
• W2897585685 hasConcept C2908647359 @default.
• W2897585685 hasConcept C2987404301 @default.
• W2897585685 hasConcept C35294091 @default.
• W2897585685 hasConcept C42219234 @default.
• W2897585685 hasConcept C71924100 @default.
• W2897585685 hasConcept C99454951 @default.
• W2897585685 hasConceptScore W2897585685C112705442 @default.
• W2897585685 hasConceptScore W2897585685C119060515 @default.
• W2897585685 hasConceptScore W2897585685C126322002 @default.
• W2897585685 hasConceptScore W2897585685C139254425 @default.
• W2897585685 hasConceptScore W2897585685C141071460 @default.
• W2897585685 hasConceptScore W2897585685C177713679 @default.
• W2897585685 hasConceptScore W2897585685C2777288759 @default.
• W2897585685 hasConceptScore W2897585685C2777390192 @default.
• W2897585685 hasConceptScore W2897585685C2908647359 @default.
• W2897585685 hasConceptScore W2897585685C2987404301 @default.
• W2897585685 hasConceptScore W2897585685C35294091 @default.
• W2897585685 hasConceptScore W2897585685C42219234 @default.
• W2897585685 hasConceptScore W2897585685C71924100 @default.
• W2897585685 hasConceptScore W2897585685C99454951 @default.
• W2897585685 hasIssue "11" @default.
• W2897585685 hasLocation W28975856851 @default.
• W2897585685 hasLocation W28975856852 @default.
• W2897585685 hasOpenAccess W2897585685 @default.
• W2897585685 hasPrimaryLocation W28975856851 @default.
• W2897585685 hasRelatedWork W1508377339 @default.
• W2897585685 hasRelatedWork W1970111863 @default.
• W2897585685 hasRelatedWork W2005101515 @default.
• W2897585685 hasRelatedWork W2007734533 @default.
• W2897585685 hasRelatedWork W2082196228 @default.

• next